 |
The Journal of Neuroscience, September 8, 2004, 24(36):7829-7836; doi:10.1523/JNEUROSCI.1751-04.2004
Previous Article | Next Article 
Neurobiology of Disease
Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex
Ernst Seiffert,1
Jens P. Dreier,2
Sebastian Ivens,1
Ingo Bechmann,3
Oren Tomkins,4
Uwe Heinemann,1 and
Alon Friedman1,4
1Johannes-Müller-Institute of Physiology, 2Experimental Neurology, and 3Center of Anatomy, Charité, University Medicine, 10117 Berlin, Germany, and 4Zlotowski Centre for Neuroscience, Ben-Gurion University, Beer-Sheva, 84105 Israel
Perturbations in the integrity of the blood-brain barrier have been reported in both humans and animals under numerous pathological conditions. Although the blood-brain barrier prevents the penetration of many blood constituents into the brain extracellular space, the effect of such perturbations on the brain function and their roles in the pathogenesis of cortical diseases are unknown.
In this study we established a model for focal disruption of the blood-brain barrier in the rat cortex by direct application of bile salts. Exposure of the cerebral cortex in vivo to bile salts resulted in long-lasting extravasation of serum albumin to the brain extracellular space and was associated with a prominent activation of astrocytes with no inflammatory response or marked cell loss. Using electrophysiological recordings in brain slices we found that a focus of epileptiform discharges developed within 4-7 d after treatment and could be recorded up to 49 d postoperatively in >60% of slices from treated animals but only rarely (10%) in sham-operated controls. Epileptiform activity involved both glutamatergic and GABAergic neurotransmission. Epileptiform activity was also induced by direct cortical application of native serum, denatured serum, or albumin-containing solution. In contrast, perfusion with serum-adapted electrolyte solution did not induce abnormal activity, thereby suggesting that the exposure of the serum-devoid brain environment to serum proteins underlies epileptogenesis in the blood-brain barrier-disrupted cortex. Although many neuropathologies entail a compromised blood-brain barrier, this is the first direct evidence that it may have a role in the pathogenesis of focal cortical epilepsy, a common neurological disease.
Key words: blood-brain; cortex; epilepsy; epileptiform; slice; somatosensory
Received Jan 8, 2004;
revised July 15, 2004;
accepted July 21, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
O Tomkins, I Shelef, I Kaizerman, A Eliushin, Z Afawi, A Misk, M Gidon, A Cohen, D Zumsteg, and A Friedman
Blood-brain barrier disruption in post-traumatic epilepsy
J. Neurol. Neurosurg. Psychiatry,
July 1, 2008;
79(7):
774 - 777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.A. van Vliet and J.A. Gorter
Reply: Complexities in the association of human blood brain barrier disruption with seizures: importance of patient population and method of disruption
Brain,
August 1, 2007;
130(8):
e78 - e78.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rigau, M. Morin, M.-C. Rousset, F. de Bock, A. Lebrun, P. Coubes, M.-C. Picot, M. Baldy-Moulinier, J. Bockaert, A. Crespel, et al.
Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy
Brain,
July 1, 2007;
130(7):
1942 - 1956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ivens, D. Kaufer, L. P Flores, I. Bechmann, D. Zumsteg, O. Tomkins, E. Seiffert, U. Heinemann, and A. Friedman
TGF-{beta} receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis
Brain,
February 1, 2007;
130(2):
535 - 547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. van Vliet, S. da Costa Araujo, S. Redeker, R. van Schaik, E. Aronica, and J. A. Gorter
Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy
Brain,
February 1, 2007;
130(2):
521 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Nash, G. Singh, A. C. White, V. Rajshekhar, J. A. Loeb, J. V. Proano, O. M. Takayanagui, A. E. Gonzalez, J. A. Butman, C. DeGiorgio, et al.
Treatment of neurocysticercosis: current status and future research needs.
Neurology,
October 10, 2006;
67(7):
1120 - 1127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lominadze, A. M. Roberts, N. Tyagi, K. S. Moshal, and S. C. Tyagi
Homocysteine causes cerebrovascular leakage in mice
Am J Physiol Heart Circ Physiol,
March 1, 2006;
290(3):
H1206 - H1213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Dreier, K. Jurkat-Rott, G. C. Petzold, O. Tomkins, R. Klingebiel, U. A. Kopp, F. Lehmann-Horn, A. Friedman, and M. Dichgans
Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II
Neurology,
June 28, 2005;
64(12):
2145 - 2147.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|